Research: Topiramate: review of safety in pregnancy

⌂Back To Homepage Subscribe To RSS Feed

Medicines Healthcare Products Regulatory Agency

June 20

10:11 2024

Print This Article Share it With Friends

Created by Medicines Healthcare Products Regulatory Agency 0 comments

This report presents the review of safety data conducted by the MHRA in 2022/2023, the advice of the CHM and the implementation group in 2023 and 2024, and the steps that the MHRA are taking to implement the new safety measures.

Published 20 June 2024

Help us improve GOV.UK

To help us improve GOV.UK, wed like to know more about your visit today.



View the original news story

Scroll Back To Top 📄More Articles

Comments

Scroll Back To Top ✎Write Comment

We don't have any comments for this article yet. Why not join in and start a discussion.

Your name:	Your email:
Comments:
Post my comment

GovWire

Research: Topiramate: review of safety in pregnancy

Medicines Healthcare Products Regulatory Agency

Is this page useful?

Help us improve GOV.UK

Help us improve GOV.UK

Related Articles

Comments

Write a Comment

Ministerial Departmental News

News Calendar

Recent Comments

Follow Us on Twitter

Share This